GlassScriptPhysician profile
Jose Medina
NPI 1417944513
$9,889.70
in general payments reported to CMS, 2019-2025
50 companies · $3,948 in 2025
The $3,948 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $831 · 2020: $1,052 · 2021: $982 · 2022: $821 · 2023: $1,020 · 2024: $1,237 · 2025: $3,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,863 · Travel and Lodging: $2,061 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,862.84 |
| Travel and Lodging | $2,060.87 |
| Education | $280.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $2,274.72 | 2025 | |
| Glaxosmithkline, LLC. | $1,698.10 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $900.46 | 2019-2025 | Ofev, Jardiance, Jascayd |
| Astrazeneca Pharmaceuticals LP | $571.86 | 2019-2025 | Airsupra, Tezspire, Farxiga |
| Regeneron Healthcare Solutions, INC. | $529.17 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $498.72 | 2019-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $446.36 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $405.56 | 2019-2025 | |
| Genzyme Corporation | $262.48 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $254.45 | 2021-2023 | Cuvitru, Glassia |
| Philips North America LLC | $236.27 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Insmed, INC. | $217.68 | 2019-2025 | Arikayce, Brinsupri |
| Inspire Medical Systems, INC. | $146.98 | 2023-2025 | Inspire |
| Baxter Healthcare | $131.87 | 2021-2025 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $127.53 | 2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $89.49 | 2019-2025 | Smartvest |
| Sanofi-Aventis U.S. LLC | $84.99 | 2025 | |
| Csl Behring | $84.52 | 2020-2024 | Haegarda |
| Verona Pharma, INC. | $82.42 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $80.09 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $69.51 | 2023-2024 | Ztlido |
| Inogen, INC. | $62.77 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Amgen INC. | $50.42 | 2023 | Otezla, Repatha |
| Kowa Pharmaceuticals America, INC. | $44.13 | 2019 | |
| Genentech USA, INC. | $42.95 | 2019 | |
| Curonix LLC | $39.15 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $38.47 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $37.93 | 2022-2024 | Opsumit |
| Pharming Healthcare, INC. | $30.99 | 2021-2024 | Ruconest |
| United Therapeutics Corporation | $30.49 | 2021 | |
| Fisher & Paykel Healthcare INC | $28.71 | 2020 | |
| Nalu Medical, INC. | $27.62 | 2025 | Nalu Neurostimulation System |
| 3b Medical, INC. | $23.81 | 2023 | Luna |
| Paratek Pharmaceuticals, INC. | $22.95 | 2019 | |
| Advanced Respiratory, INC | $22.93 | 2021 | |
| Novo Nordisk INC | $22.62 | 2024 | Rybelsus |
| Pulmonx Corporation | $20.40 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Lilly USA, LLC | $19.65 | 2021 | |
| Circassia INC. | $18.64 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.20 | 2023 | Relistor |
| Mylan Specialty L.P. | $17.07 | 2019 | |
| Eisai INC. | $16.78 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.27 | 2024 | |
| Olympus America INC. | $16.01 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $15.12 | 2025 | Lumryz |
| Axsome Therapeutics, INC. | $13.39 | 2025 | Sunosi |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Medina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.